LEXINGTON, Mass.--(BUSINESS WIRE)--EPIX Pharmaceuticals, Inc. (NASDAQ: EPIX) announced today that the United States Patent and Trademark Office will issue to EPIX patent number 7,153,858, entitled “New Arylpiperazinyl Compounds.” The granted claims of the patent include the class of selective 5-HT1A binding compounds discovered by EPIX, pharmaceutical compositions containing them, and specific compounds, including PRX-00023.
